This study suggests that deregulation of the TRIM17/TRIM41/ZSCAN21 pathway may be involved in the pathogenesis of PD [81], targeting this pathway holds a lot of promise for PD treatment. This evidence concerns the gene ZSCAN21 and Parkinson disease.